Nuformix loss widens as revenue drops
15th Jul 2021 10:23
(Sharecast News) - Nuformix's annual loss widened as revenue fell and the pharmaceutical company spent to development its treatments.
Read moreNuformix seeks chairman as Blackwell quits after a year
10th Feb 2021 10:18
(Sharecast News) - Chris Blackwell has quit as Nuformix's chairman a year after taking the job at the drug development company.
Read moreNuformix inks cannabinoid therapeutics deal with Ebers Tech
9th Apr 2019 11:25
(Sharecast News) - Pharmaceutical development company Nuformix has inked an agreement for cannabinoid therapeutics development, licensing and commercialisation with Canadian outfit Ebers Tech.
Read moreMHRA gives go-ahead to Nuformix for human studies
27th Feb 2019 10:48
(Sharecast News) - Pharmaceutical development company Nuformix has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to begin human pharmacokinetics studies for its lead asset, NXP001, it announced on Wednesday.
Read more